VRECOVERY: The Effect of Virtual Reality on Postoperative Pain and Anxiety in Cardiac Surgery.

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Other)
Overall Status
Recruiting
CT.gov ID
NCT06001502
Collaborator
(none)
100
1
2
12
8.3

Study Details

Study Description

Brief Summary

The objective of this study is to investigate the effect of VR on post-operative pain and anxiety management in cardiac surgery patients undergoing a coronary artery bypass grafting (CABG) procedure.

Participants in the intervention group will receive a 20 minute session with the head mounted VR device on post-operative days 1,2 and 3.

Participants in the control group will be treated with conventional post-operative care.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual Reality distraction therapy
N/A

Detailed Description

Objective: The objective of this study is to investigate the effect of VR on post-operative pain and anxiety management in cardiac surgery patients undergoing a coronary artery bypass grafting (CABG) procedure.

Study design: This study is a single-center randomized control trial.

Study population: Patients who have undergone a CABG procedure (n=100).

Intervention: The intervention group (n=50) will use the VR distraction therapy device at day 1, 2 and 3 after surgery on the general ward. The control group (n=50) will be treated with conventional post-operative pain and anxiety management.

Main study parameters/endpoints: The main study parameters at day 1, 2 and 3 after surgery. These are the Numeric Rating Scale (NRS) to assess the effect of pain on mobility, the Quality of Recovery-15 questionnaire, the State-Trait Anxiety Inventory-6 questionnaire and assessment of analgesic use. At follow-up, participants will be called to gather one-time QoR-15 and STAI-6 questionnaire data 6 weeks after the surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Virtual Reality on Postoperative Pain and Anxiety in Cardiac Surgery.
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Reality group

Virtual Reality distraction therapy on post-operative days 1,2 and 3.

Device: Virtual Reality distraction therapy
The VR device simulates a 3-dimensional virtual enviroment, seeking to immerse the user in virtual surroundings
Other Names:
  • Healthy Mind VR device
  • No Intervention: Control Group

    Conventional post-operative pain and anxiety management

    Outcome Measures

    Primary Outcome Measures

    1. Numeric Rating Scale (NRS) [Post-operative days 1,2 and 3 directly after the VR intervention]

      The NRS score is a numeric scale in which individuals rate pain from 0 (no pain) tot 10 (worst pain). This is a subjective score which is assessed verbally and used frequently in standard clinical care in multiple medical specialties.

    2. State- Trait Anxiety Inventory 6 questionnaire [Post-operative days 1,2 and 3 directly after the VR intervention]

      The STAI-6 questionnaire is a validated psychological inventory designed to measure worry, tension and anxiety in an individual. It is a shortend version of the STAI score

    3. Quality of Recovery-15 [Post-operative days 1,2 and 3 directly after the VR intervention]

      The QoR-15 questionnaire is a clinical validated instrument to measure post-operative quality of recovery.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age ≥18 years or older with written informed consent

    • Patients undergoing surgical CABG

    Exclusion Criteria:
    • Major comorbidities besides coronary artery disease

    • Complicated surgical procedure

    • Hearing and/or visual impairments

    • Psychiatric impairments

    • Complaints of vomiting and nausea

    • History of epilepsy

    • Claustrophobia

    • Facial wounds and skin defects at site of application

    • Patients placed in clinical isolation

    • Readmission to the intensive care unit

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Academic Medical Center Amsterdam Noord Holland Netherlands 1105 AZ

    Sponsors and Collaborators

    • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    Investigators

    • Principal Investigator: Jolanda Kluin, MD, PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Jolanda Kluin, Professor dr. J. Kluin, MD, PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
    ClinicalTrials.gov Identifier:
    NCT06001502
    Other Study ID Numbers:
    • NL79616.018.21
    First Posted:
    Aug 21, 2023
    Last Update Posted:
    Aug 21, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 21, 2023